2022
DOI: 10.1016/j.cca.2022.09.023
|View full text |Cite
|
Sign up to set email alerts
|

Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: Innate immunity, taste perception and FABP5 proteins make the difference

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 37 publications
1
3
0
Order By: Relevance
“…A similar study found 70 different peaks on CM10 chips (39 in the range of 2-10 kDa, 17 from 10-20 kDa, and 14 from 20-100 kDa) and a total of 108 peaks on the Q10 chips with most peaks in the range of below 10 kDa [43]. These findings are in line with the results of the present investigation, while other studies reported from total numbers that ranged between 70 and >1000 proteins [14,[44][45][46].…”
Section: Discussionsupporting
confidence: 92%
“…A similar study found 70 different peaks on CM10 chips (39 in the range of 2-10 kDa, 17 from 10-20 kDa, and 14 from 20-100 kDa) and a total of 108 peaks on the Q10 chips with most peaks in the range of below 10 kDa [43]. These findings are in line with the results of the present investigation, while other studies reported from total numbers that ranged between 70 and >1000 proteins [14,[44][45][46].…”
Section: Discussionsupporting
confidence: 92%
“…Peptides were separated by reverse-phase chromatography with a C18 column (Brownlee SPP Peptide ES C18, 100 mm × 2.1 mm i.d., 2.7 μm particle size, PerkinElmer, Waltham, MA) with a 45 min gradient and an injection volume of 4 μL. The detailed instrument parameters are reported in Aita et al 45 A total of 35 individual samples were randomly analyzed in 5 days, alternated with two pool injections per day as QC. The SRM transitions (at least five for each peptide) were initially chosen based on the manual scrutiny of MS/MS spectra acquired in the untargeted analysis and then experimentally optimized by determining the best collision energy and S-lens values.…”
Section: Methodsmentioning
confidence: 99%
“… Cancer biomarkers : Salivary proteomic biomarkers have been investigated as potential indicators of cancer in various organs, including the breast, lung, prostate, and head and neck 81–83 . These biomarkers can include proteins that are specific to the tumor or proteins that are over‐ or under‐expressed in cancer patients. Infectious disease biomarkers : Salivary proteomic biomarkers have been investigated as a potential tool for diagnosing infectious diseases such as human immunodeficiency virus (HIV), hepatitis B and C, and SARS‐CoV‐2 spike antigens 84,85 . Specific proteins in saliva can be used to detect the presence of viral or bacterial infections and monitor disease progression. Neurological biomarkers : Salivary proteomic biomarkers have been investigated as a potential tool for diagnosing and monitoring neurological conditions such as Alzheimer's disease and Parkinson's disease 83,86 .…”
Section: The Nature Of Salivamentioning
confidence: 99%
“…Infectious disease biomarkers: Salivary proteomic biomarkers have been investigated as a potential tool for diagnosing infectious diseases such as human immunodeficiency virus (HIV), hepatitis B and C, and SARS-CoV-2 spike antigens. 84,85 Specific proteins in saliva can be used to detect the presence of viral or bacterial infections and monitor disease progression. 4.…”
Section: Proteomic Biomarkersmentioning
confidence: 99%